Home - Products - GPCR/G Protein - Calcium Channel - Calcium Channel antagonist 2

Calcium Channel antagonist 2

CAS No. 874370-15-7

Calcium Channel antagonist 2( —— )

Catalog No. M37073 CAS No. 874370-15-7

Calcium Channel antagonist 2 is a calcium channel antagonist (IC50=5-20 μM) that can be used to study diseases due to Ca2+ channels like pain and diabetes.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	37	In Stock
25MG	57	In Stock
50MG	84	In Stock
100MG	120	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Calcium Channel antagonist 2
Note

Research use only, not for human use.
Brief Description

Calcium Channel antagonist 2 is a calcium channel antagonist (IC50=5-20 μM) that can be used to study diseases due to Ca2+ channels like pain and diabetes.
Description

Calcium Channel antagonist 2 (Compound 154) is a calcium channel antagonist (IC50=5-20 μM). Calcium Channel antagonist 2 can be used in study of calcium channel-mediated diseases such as pain and diabetes.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Calcium Channel
Recptor

Calcium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

874370-15-7
Formula Weight

444.52
Molecular Formula

C23H25FN2O4S
Purity

>98% (HPLC)
Solubility

——
SMILES

CC=1C=2C(OC1C(NCC3=CC=C(F)C=C3)=O)=CC=C(S(=O)(=O)N4CCC(C)CC4)C2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Andreas P Termin, et al. Heterocyclic derivatives for modulation of calcium channels. Patent WO2006010008A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Lifarizine

Lifarizine (RS-87476), a calcium-sodium channel antagonist, shows neuroprotective activity in a simplified rat survival model of double vessel occlusion.
MK-8998

MK-8998 (CX-8998) is a potent and selective antagonist of the T-type calcium channel for the treatment of schizophrenia.
CBD3063

CBD3063 is a CRMP2-based peptidomimetic small molecule with analgesic and neuroprotective effects, which can allosterically regulate Cav 2.2 and can be used to study neurological diseases.

Sign In Join Free